Bifunctional Nanoassembly Enables Metabolism-Driven Microfluidic Blood Screening Guided by MRI Localization for...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Diagnostics

Background:

• Early cancer detection is crucial but challenged by limitations of endogenous biomarkers.
• Current diagnostic methods often require sequential, invasive procedures.

Purpose of the Study:

• To develop a multimodal nanosensor for enhanced cancer detection and localization.
• To create a system for amplifying disease signals and enabling multimodal monitoring.

Main Methods:

• Engineered a nanosensor targeting CD44 and tumor-associated enzymes.
• Nanosensor delivers hexaminolevulinate (HAL) to produce protoporphyrin IX (PpIX) synthetic biomarker.
• Integrated Gd2O3 nanoclusters for MRI visualization and microfluidics for signal analysis.

Main Results:

• Nanosensor selectively accumulates at disease sites, amplifying diagnostic signals.
• Enabled multimodal tumor visualization and monitoring of drug response.
• Demonstrated enhanced diagnostic efficiency compared to traditional methods.

Conclusions:

• The multimodal nanosensor offers a promising approach for early cancer diagnosis and personalized treatment.
• This technology overcomes limitations of traditional diagnostics, reducing invasiveness.
• Facilitates accurate, efficient, and multimodal cancer care.